Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report) shot up 0% during mid-day trading on Friday . The company traded as high as GBX 1,629.64 ($20.51) and last traded at GBX 1,626.79 ($20.47). 8 shares were traded during trading, a decline of 100% from the average session volume of 1,655 shares. The stock had previously closed at GBX 1,626 ($20.46).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The company has a debt-to-equity ratio of 0.04, a quick ratio of 9.27 and a current ratio of 9.42. The business has a 50 day simple moving average of GBX 1,639.41 and a 200-day simple moving average of GBX 1,573.32. The firm has a market cap of £4.81 billion and a price-to-earnings ratio of -1,478.90.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
(
Get Free Report)
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation wasn't on the list.
While First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
